CD19 and neoplasm: Following preliminary analysis of tumors, single cell suspensions were made and tumor cells were analyzed by flow cytometry to determine if the presence of vIL-6 influenced gene expression of common B cell markers on tumor cells (CD45, CD19, CD20, CD22, CD30, and CD138).